Is Osiris Therapeutics, Inc. (OSIR) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Osiris Therapeutics Inc. (OSIR)
Market is closed
News
- 1 - 10
- Next >>
Is Osiris Therapeutics, Inc. (OSIR) A Good Stock To Buy?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Osiris Therapeutics, Inc. (OSIR) Stock Discontinues Trial Enrollment
Osiris Therapeutics, Inc. (NASDAQ:OSIR) took it on the chin yesterday morning after the company released news through an 8-K filing.
What's the Deal With These Stocks Getting Pounded?
It's been a Friday to forget for many bullish investors as the NASDAQ index opened in the red and continues to decline in late morning trading as valuation worries and concerns about the global economy...
Why Are These Stocks Deep In the Red Today?
With the market plunging further in the intraday trading on Friday, shares of Walt Disney Co (NYSE:DIS), Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Great Basin Scientific Inc (NASDAQ:GBSN), Osiris Therapeutics...
Osiris Therapeutics, Inc. (OSIR): Are Hedge Funds Right About This Stock?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because they are without...
Why Are These Four Stocks Tanking Amid Today's Rally?
U.S stocks are trending higher today following some positive economic data.
Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
At the moment, there are plenty of metrics market participants can use to monitor the equity markets. A pair of the most underrated are hedge fund and insider trading activity.
Osiris Therapeutics, Inc. (OSIR), Derma Sciences Inc (DSCI): The Changing Landscape in Chronic Diabetic Foot Ulcers
While the market of treating chronic diabetic foot ulcers is by no means glamorous, it can still be a very lucrative indication.
Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
- 1 - 10
- Next >>
Billionaire Hedge Funds
